The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
about
Modulation of NF-κB signalling by microbial pathogensFrequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1.Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expressionChanges in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity.NF-kappaB activation in melanoma.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.TRAF6 is a critical regulator of LMP1 functions in vivo.The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.Macropinocytosis and TAK1 mediate anti-inflammatory to pro-inflammatory macrophage differentiation by HIV-1 NefCharacterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6.Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1Epstein-Barr Virus LMP1 Mediated Oncogenicity.Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation.Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
P2860
Q28709497-0F634C14-2FDE-416F-A2A9-49A3CCB65009Q33738811-2991F3FF-84FE-4472-B88F-973B75BB16AAQ33756614-13FCAC78-CB75-476F-9DD0-F3CB1710DEEAQ34241279-8F0DBC6E-28F7-4740-967C-20771C8097EBQ34352790-209A92BC-4462-4419-A980-E1F8CFF87C9DQ34364910-D74F0EED-A5C8-4917-AE4C-AC2B65C4A28BQ34384112-49FE37F6-FB6C-4622-A682-096E7828E09DQ34479733-7292F57F-5D2E-4448-ABE5-1958F6029703Q34696221-5E3667CA-C6DD-461E-84E8-7FFD77891D0DQ35235728-6D47884F-F607-4D03-B589-4EBB27AED0EBQ35677629-89589399-877D-4C57-8A90-8327FDBD4367Q36327896-A71F53EC-BEC6-4937-A778-2F8DAE116D6DQ36416479-8BCA487F-70E9-4842-BB0A-959943FD35A6Q37016499-EBA49541-52D1-4BE3-ABFE-D60DE2370179Q37073277-B95F7EC2-D5C3-4F4A-B5E1-2A3FFD8FBB37Q37145244-CC1E26BF-BF3A-496E-B8C5-712E157B3535Q37247067-7B6E96E3-4386-41B2-AACD-98CA1220C12BQ37610522-02C8E902-5D70-4E43-8245-108497DC2841Q38264787-833EEC92-49F2-4F15-81FC-690C7ACA4A2CQ38722933-62151751-8973-4FF0-B340-2A28FB7D7CB9Q38834569-A527CC70-96C5-4C1B-860A-07ECACE22C45Q38990423-F30D1B58-C050-4CE5-9820-22EDCAB59486Q39594162-DEE58DD9-61BD-468F-ACE2-6AB3DA1B5E92Q39789708-B79770FD-8DC9-45B6-86ED-A0EC5CCA27E3Q39949585-92994F67-954E-4430-9ED9-300C1CB743F1Q40073030-AB530DAC-71DE-4648-8BE7-9211A0117D1FQ40091077-BC31A89D-0BF1-4069-9168-EAC40F77203BQ40209246-5C05914A-30C9-408E-AF12-A8697B26A758Q41981419-81787526-AA61-4770-BCAD-17E39E30EFF8Q42045465-6663FE23-91C4-47E5-8FC4-C1281D4DE0AAQ42065930-C0684834-8233-4B38-B431-2BA1B4680ED2Q42780131-C3409E35-9652-4147-8AE9-85A7982DB796
P2860
The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The C-terminal activating regi ...... kappaB through TRAF6 and TAK1.
@en
type
label
The C-terminal activating regi ...... kappaB through TRAF6 and TAK1.
@en
prefLabel
The C-terminal activating regi ...... kappaB through TRAF6 and TAK1.
@en
P2093
P2860
P356
P1476
The C-terminal activating regi ...... kappaB through TRAF6 and TAK1.
@en
P2093
Hiroyasu Nakano
Zhenguo Wu
P2860
P304
P356
10.1074/JBC.M505903200
P407
P577
2005-11-08T00:00:00Z